Association of the DTNBP1 locus with schizophrenia in a U.S. population

American Journal of Human Genetics

Volumn 75, Issue 5, 2004, Pages 891-898

  Funke, Birgit ^a   Finn, Christine T ^a   Plocik, Alex M ^a   Lake, Stephen ^a   DeRosse, Pamela ^b   Kane, John M ^b   Kucherlapati, Raju ^a,c   Malhotra, Anil K ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DYSTROBREVIN; DYSTROBREVIN BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; SAMPLING; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

EID: 6344237686     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/425279     Document Type: Article

References (34)

1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES (2000) The common PRARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
2. Anderson JL, Head SI, Rae C, Morley JW (2002) Brain function in Duchenne muscular dystrophy. Brain 125:4-13
3. Ardlie KG, Lunetta KL, Seielstad M (2002) Testing for population subdivision and association in four case-control studies. Am J Hum Genet 71:304-311
4. Avila MT, Hong E, Thaker GK (2002) Current progress in schizophrenia research. Eye movement abnormalities in schizophrenia: what is the nature of the deficit? J Nerv Ment Dis 190:479-480
5. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ (2001) Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276:24232-24241
6. Botstein D, Risch N (2003) Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet Suppl 33: 228-237
7. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC (2003) Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 113:149-153
8. Cardno AG, Gottesman II (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97:12-17
9. Collier DA, Li T (2003) The genetics of schizophrenia: glutamate not dopamine? Eur J Pharmacol 480:177-184
10. Hill WG (1974) Estimation of linkage disequilibrium in randomly mating populations. Heredity 33:229-239
11. Hinton VJ, De Vivo DC, Nereo NE, Goldstein E, Stern Y (2000) Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurology 54:2127-2132
12. Kirov G, Ivanov D, Williams NM, Preece A, Nikolov I, Milev R, Koleva S, Dimitrova A, Toncheva D, O'Donovan MC, Owen MJ (2004) Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 55:971-975
13. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Heredity 55:56-65
14. Levinson DF, Mowry BJ (2000) Genetics of schizophrenia. In: Pfaff DW, Berrettini WH, Joh TH, Maxson SC (eds) Genetic influences on neural and behavioral functions. CRC Press, New York, pp 47-82
15. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, et al (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73:34-48
16. Lui F, Fonda S, Merlini L, Corazza R (2001) Saccadic eye movements are impaired in Duchenne muscular dystrophy. Doc Ophthalmol 103:219-228
17. McGuffin P, Owen MJ, Farmer AE (1995) Genetic basis of schizophrenia. Lancet 346:678-682
18. Mehler MF (2000) Brain dystrophin, neurogenetics and mental retardation. Brain Res Brain Res Rev 32:277-307
19. Morris DW, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Waddington JL, Gill M, Corvin AP (2003) No evidence for association of the dysbindin gene (DTNBP1) with schizophrenia in an Irish population-based study. Schizophr Res 60:167-172
20. Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731-740
21. North KN, Miller G, Iannaccone ST, Clemens PR, Chad DA, Bella I, Smith TW, Beggs AH, Specht LA (1996) Cognitive dysfunction as the major presenting feature of Becker's muscular dystrophy. Neurology 46:461-465
22. Pankow JS, Province MA, Hunt SC, Arnett DK (2002) Regarding "Testing for population subdivision and association in four case-control studies." Am J Hum Genet 71:1478-1480
23. Risch N (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46:222-228
24. Risch NJ (2000) Searching for genetic determinants in the new millennium. Nature 405:847-856
25. Sasieni PD (1997) From genotypes to genes: doubling the sample size. Biometrics 53:1253-1261
26. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434
27. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, Wildenauer DB (2003) Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 72:185-190
28. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71:337-348
29. Straub V, Campbell KP (1997) Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol 10: 168-175
30. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113:1353-1363
31. Tang JX, Zhou J, Fan JB, Li XW, Shi YY, Gu NF, Feng GY, Xing YL, Shi JG, He L (2003) Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 8:717-718
32. Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, Becker T, Freudenberg J, Jonsson EG, Mattila-Evenden M, Sedvall GC, Czerski PM, Kapelski P, Hauser J, Maier W, Rietschel M, Propping P, Nothen MM, Cichon S (2003) The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 73:1438-1443
33. van den Oord EJ, Sullivan PF, Jiang Y, Walsh D, O'Neill FA, Kendler KS, Riley BP (2003) Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry 8:499-510
34. Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, Stephens M, Norton N, Williams H, Clement M, Dwyer S, Curran C, Wilkinson J, Moskvina V, Waddington JL, Gill M, Corvin AP, Zammit S, Kirov G, Owen MJ, O'Donovan MC (2004) Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 61:336-344